Comparison of Factor VIII Transgenes Bioengineered for Improved Expression in Gene Therapy of Hemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Factor VIII Transgenes Bioengineered for Improved Expression in Gene Therapy of Hemophilia A

Published:2009-05 Issue:5 Volume:20 Page:465-478
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Dooriss Kerry L.¹²,Denning Gabriela³,Gangadharan Bagirath²,Javazon Elisabeth H.²,McCarty David A.²,Spencer H. Trent²³,Doering Christopher B.²³

Affiliation:

1. Molecular and Systems Pharmacology Graduate Program, Emory University School of Medicine, Atlanta, GA 30322.

2. Aflac Cancer Center and Blood Disorders Services, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322.

3. Expression Therapeutics, Tucker, GA 30084.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2008.150

Reference50 articles.

1. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector

2. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules

3. Correction of Murine Hemophilia A and Immunological Differences of Factor VIII Variants Delivered by Helper-dependent Adenoviral Vectors

4. Stem cell–derived erythroid cells mediate long-term systemic protein delivery

5. Sustained expression of human factor VIII in mice using a parvovirus-based vector

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII;Frontiers in Immunology;2022-12-15

2. Molecular therapeutics of hemophilia A and B;Expert Review of Hematology;2022-05-04

3. Hemophilia A gene therapy: current and next-generation approaches;Expert Opinion on Biological Therapy;2022-01-06

4. Identification of coagulation factor IX variants with enhanced activity through ancestral sequence reconstruction;Blood Advances;2021-08-27

5. Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A;Frontiers in Cell and Developmental Biology;2021-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3